CLASS II Device recall · Reported 28 Apr 2021 · FDA Enforcement Report

DirectInject consists of a sterile dual paste system recalled

Stryker Leibinger GmbH & Co. KG is recalling DirectInject consists of a sterile dual paste system which is calcium phosphate based, distributed nationwide in the US. The recall was initiated on 1 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: DI20311,DI20307 Product Code (UDI): 07613327123265
Quantity recalled321 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1436-2021
FDA event ID
87684
Recalling firm
Stryker Leibinger GmbH & Co. KG, Freiburg Im Breisgau, N/A
Classification
Class II
Status
Terminated
Recall initiated
1 Apr 2021
FDA classified
19 Apr 2021
Reported
28 Apr 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

1 Apr 2021Recall initiated by company
19 Apr 2021Classified by FDA+18 days
28 Apr 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Inability for the user to inject the paste from the syringe into the target location.

Product as listed by the FDA

DirectInject consists of a sterile dual paste system which is calcium phosphate based. Upon injection through the Mixer-Cannula, the two pastes form a cement paste which is moldable. The injected cement paste will harden under normal body conditions to form hydroxyapatite.

Where it was distributed

Worldwide distribution - US Nationwide distribution and the countries of Germany, Italy, France, Australia, Japan.

Nationwide

Questions about this recall

Why was it recalled?

Inability for the user to inject the paste from the syringe into the target location.

Which lots are affected?

Lot: DI20311,DI20307 Product Code (UDI): 07613327123265

Where was it sold?

Worldwide distribution - US Nationwide distribution and the countries of Germany, Italy, France, Australia, Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Stryker Leibinger GmbH & Co. KG

All 26

Other Heart & Vascular Devices recalls

All 6,270